Cisbio to Distribute BellBrook's Assay for Epigenetics Research | GenomeWeb

NEW YORK (GenomeWeb News) – Cisbio Bioassays today announced a deal to distribute BellBrook Labs' Transcreener Epigen Methyltransferase assay.

Under the terms of the agreement, the second distribution deal between the companies, Cisbio will offer the assay for epigenetics-based drug discovery studies conducted by pharmaceutical and biotechnology researchers in the US, Europe, and Asia.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.